Company profile for 22nd Century Group

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

22nd Century Group, Inc. is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding. Our primary mission in tobacco is to reduce the harm caused by smoking by bringing our reduced nicotine content tobacco cigarettes – containing 95% less nicotine t...
22nd Century Group, Inc. is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding. Our primary mission in tobacco is to reduce the harm caused by smoking by bringing our reduced nicotine content tobacco cigarettes – containing 95% less nicotine than conventional cigarettes – to adult smokers in the U.S. and international markets. Our mission in hemp/cannabis is to develop and commercialize proprietary hemp/cannabis plants.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
500 Seneca Street, Suite 507 Buffalo, NY 14204
Telephone
Telephone
716-270-1523
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com//news-release/2023/12/04/2789899/0/en/22nd-Century-Secures-3-2-Million-to-Date-in-Warrant-Exchange-Transaction.html

GLOBENEWSWIRE
04 Dec 2023

https://www.globenewswire.com//news-release/2023/11/29/2787621/0/en/22nd-Century-Appoints-Larry-Firestone-as-Chairman-and-CEO.html

GLOBENEWSWIRE
29 Nov 2023

https://www.globenewswire.com//news-release/2023/11/27/2786543/0/en/22nd-Century-Group-Enters-into-Agreement-to-Sell-Hemp-Cannabis-Franchise.html

GLOBENEWSWIRE
27 Nov 2023

https://www.globenewswire.com//news-release/2023/11/08/2776588/0/en/22nd-Century-Group-Continues-VLN-Expansion-Now-Retailing-in-More-Than-5-100-Stores.html

GLOBENEWSWIRE
08 Nov 2023

https://www.globenewswire.com//news-release/2023/11/07/2775148/0/en/22nd-Century-Group-XXII-Expands-Reduced-Nicotine-Content-Tobacco-IP-with-Latest-Technology-License.html

GLOBENEWSWIRE
07 Nov 2023

https://www.globenewswire.com//news-release/2023/11/06/2773978/0/en/22nd-Century-Group-XXII-Reports-Third-Quarter-2023-Financial-Results.html

GLOBENEWSWIRE
06 Nov 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty